Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00386958Phase 2Completed
Phase 2, randomised, open-label trial of povidone-iodine in bacterial keratitis (4 arms), sponsored by The Lundquist Institute. Primary endpoints: Days to cure and Safety of study medication. Started Nov 2002; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00386958.